Infective pulmonary exacerbation of cystic fibrosis and Rales

Summary:

Rales is reported only by a few people with Infective pulmonary exacerbation of cystic fibrosis.

The study analyzes which people have Rales with Infective pulmonary exacerbation of cystic fibrosis. It is created by eHealthMe based on 2 people who have Rales and Infective pulmonary exacerbation of cystic fibrosis from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 28, 2023

2 people who have Infective Pulmonary Exacerbation Of Cystic Fibrosis and Rales are studied.

What is Infective pulmonary exacerbation of cystic fibrosis?

Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus) is found to be associated with 621 drugs and 201 conditions by eHealthMe.

What is Rales?

Rales (an abnormal respiratory sound characterized by fine crackles) is found to be associated with 1,636 drugs and 934 conditions by eHealthMe.

Number of Rales in Infective pulmonary exacerbation of cystic fibrosis reports submitted per year:

Would you have Rales when you have Infective pulmonary exacerbation of cystic fibrosis?

Gender of people who have Infective Pulmonary Exacerbation Of Cystic Fibrosis and experienced Rales *:

female: 50 %
male: 50 %

Age of people who have Infective Pulmonary Exacerbation Of Cystic Fibrosis and experienced Rales *:

Common co-existing conditions for these people *:

Cystic Fibrosis (disease of the secretary glands): 2 people, 100.00%
Underweight: 1 person, 50.00%
Pancreatic Insufficiency: 1 person, 50.00%
Cystic Fibrosis Related Diabetes: 1 person, 50.00%

Common drugs taken by these people *:

Common symptoms for these people *:

Productive Cough: 2 people, 100.00%
Weight Decreased: 2 people, 100.00%
Cough: 2 people, 100.00%
Respiratory Rate Increased (excess breathing rate/min): 2 people, 100.00%
Weight Increased: 1 person, 50.00%
Heart Rate Increased: 1 person, 50.00%
Fever: 1 person, 50.00%
Fatigue (feeling of tiredness): 1 person, 50.00%
Dyspnea Exertional: 1 person, 50.00%
Cystic Fibrosis (disease of the secretary glands): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Rales?

Check whether Rales is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Infective pulmonary exacerbation of cystic fibrosis (5,971 reports)
Rales (7,995 reports)

COVID vaccines that are related to Rales:

Common drugs associated with Rales:

All the drugs that are associated with Rales:

Rales (1,636 drugs)

Common conditions associated with Rales:

Asthma: 989 reports
Rheumatoid arthritis: 458 reports
High blood pressure: 444 reports
Primary pulmonary hypertension: 321 reports
Atrial fibrillation/flutter: 194 reports

All the conditions that are associated with Rales:

Rales (934 conditions)

How the study uses the data?

The study is based on Rales and Infective pulmonary exacerbation of cystic fibrosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.